All FAQs
FAQlifestyle

Can I skip a dose without messing up my cycle?

Yes — occasional missed doses don't ruin most peptide cycles. Don't double up to catch up. The impact varies by peptide half-life and dosing frequency.

Updated May 8, 2026 · 6 min read


Yes — occasional missed doses are fine for most peptides. The cycle isn't ruined by one or two skipped injections. Don't double up the next day to "catch up" — that just exposes you to a higher peak dose with no benefit. The impact of a missed dose depends on the peptide's half-life and how often it's normally dosed. A missed daily dose is barely noticeable. A missed weekly dose of a long-acting compound is also barely noticeable. The pattern that matters is whether skipping becomes habitual.

The honest framing: cycle protocols assume reasonable adherence, not perfect adherence. Missing 5-10% of doses across a cycle won't change the outcome meaningfully for any peptide on this site.

By peptide and frequency

Different peptides handle missed doses differently:

PeptideNormal cadenceMissing one dose
BPC-157Daily SubQNo big deal — resume normal dosing the next day
TB-500Twice weekly loading, then weekly/biweeklyNegligible — long half-life smooths it out
Ipamorelin1-3x dailySkipping the pre-bed dose loses one GH pulse — minor
CJC-1295 (no DAC)Paired with IpaSame as Ipa — minor
CJC-1295 with DACWeeklyNegligible — long half-life means you have residual peptide for days
SermorelinPre-bed dailyNegligible for one night
MK-677Daily oralNegligible — half-life is hours but the receptor activity smooths over a day
IGF-1 LR3DailyModest impact — short cycle means each dose carries more weight
MOTS-c2-3x weeklyNegligible
GHK-CuDaily topical or 2-3x weekly injectionNegligible
TesamorelinDailyNegligible for one day

The "don't double up" rule

The temptation to take twice the next dose to make up for a missed one is wrong for every peptide on this list. The reasoning:

Peptide classWhy doubling is wrong
BPC-157, TB-500More peptide doesn't accelerate tissue healing past the dose-response curve
GH secretagoguesDoubling stacks side effects (water retention, glucose drift) without doubling effect
IGF-1 LR3Doubling the dose materially increases hypoglycemia risk
MK-677Doubling extends the post-dose ghrelin effect; appetite, water retention, sleep effects all amplified

The right move is always: skip the missed dose, resume normal dosing on schedule.

How many missed doses before it matters?

Rough guidance — these aren't bright lines:

PatternImpact
1 missed dose in a 4-6 week cycleNone noticeable
2-3 missed doses scattered across a cycleNegligible for most peptides
5%+ of total doses missedProbably a slight reduction in effect; not enough to abandon the cycle
10%+ of total doses missedApproaching the threshold where you should ask whether the protocol is fitting your life
1-2 missed days in a rowFor daily peptides, 1-2 day gaps are fine; for IGF-1 LR3 specifically, try harder to maintain the pattern
1+ week gapNot really a missed dose — you've taken a break. Treat as cycle interruption.

For longer gaps, see can I restart peptides if I stopped early.

The pre-bed GH-secretagogue case

The most common "should I take it" decision is the pre-bed Ipa+CJC dose when you forgot earlier in the day. The framework:

  • If you remember within 1 hour of intended dose time: take it.
  • If you're already going to bed: skip. The dose timing matters because GH secretagogues are designed to amplify a sleep-onset GH pulse. A late-night dose past sleep onset doesn't do what the protocol intended.
  • Don't take it earlier in the next morning to compensate. The morning dose hits a different physiological window than the pre-bed dose.

Lost one GH pulse over a 12-week cycle is not a meaningful loss.

The IGF-1 LR3 case

IGF-1 LR3 is the one peptide where missed doses matter slightly more, for two reasons:

  1. The cycle is short (4-6 weeks). Each dose is a larger fraction of the total cycle exposure.
  2. The peptide has a measurable acute effect (hypoglycemia risk in the post-injection window). Skipping isn't dangerous, but the protocol is built around consistent daily exposure.

Even with IGF-1 LR3, a single missed dose isn't a problem. Don't double up. Resume on schedule.

The CJC-1295 DAC case

This is the cleanest "missed dose, no problem" peptide on the list. CJC-1295 with DAC has roughly a 7-day half-life. Missing the weekly injection by a day or two has almost no detectable effect — there's still a meaningful concentration of peptide in your system from the previous dose.

The standard advice: if you forgot Monday's injection and remember Tuesday, take it Tuesday and shift the schedule, or take it Tuesday and return to Monday the following week. Either is fine. Don't take a second dose later that week to "catch up to schedule."

When skipping signals a different problem

The honest version: most missed doses aren't accidents. They're early signals about whether the protocol fits your life.

PatternWhat it might mean
Forgetting once a weekReasonable — life happens
Forgetting consistently on certain days (e.g., weekends, travel days)Protocol-life mismatch; consider adjusting cadence
Avoiding the injection because of the injection itselfSubcutaneous fatigue, vendor issue, or psychological resistance — worth examining
Skipping because side effects are piling upThis isn't "missing a dose" — it's an unannounced stop. See when should I stop a peptide cycle early.
Running out of vials before the cycle endsInventory issue; plan ahead next time

If the missed-dose pattern is structural rather than incidental, the question isn't really "can I skip a dose." It's "is this the right protocol for my life."

Tracking what you actually took

The simplest correction to dose-skipping is writing it down. A short log:

  • Date and time of injection
  • Dose
  • Site (rotate sites)
  • Vial batch
  • Anything notable (skip reason, side effect, etc.)

Cycles look different in retrospect when you have actual data versus memory. "I think I was pretty consistent" usually means worse than 90% adherence; written logs typically show worse compliance than people remember.

For more on dosing precision, see common dosing errors.